These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7015908)

  • 21. Intercellular IgA dermatosis.
    Ongenae KC; Temmerman LJ; Vermander F; Naeyaert JM
    Eur J Dermatol; 1999 Mar; 9(2):85-94. PubMed ID: 10066953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cicatricial pemphigoid in D-penicillamine treated patients with rheumatoid arthritis--a report of three cases.
    Shuttleworth D; Graham-Brown RA; Hutchinson PE; Jolliffe DS
    Clin Exp Dermatol; 1985 Jul; 10(4):392-7. PubMed ID: 3899425
    [No Abstract]   [Full Text] [Related]  

  • 23. Cicatricial pemphigoid associated with D-penicillamine treatment.
    Martí-Huguet T; Quintana M; Cabiró I
    Arch Ophthalmol; 1989 Aug; 107(8):1115. PubMed ID: 2667506
    [No Abstract]   [Full Text] [Related]  

  • 24. Depot sulfonamid associated linear IgA bullous dermatosis with erythema multiforme-like clinical features.
    Tonev S; Vasileva S; Kadurina M
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):165-8. PubMed ID: 9784046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benign mucous-membrane pemphigoid associated with penicillamine treatment.
    Pegum JS; Pembroke AC
    Br Med J; 1977 Jun; 1(6074):1473. PubMed ID: 324578
    [No Abstract]   [Full Text] [Related]  

  • 26. [Induced pemphigus].
    Enjolras O; Sedel D; Leibowitch M; Escande JP
    Ann Dermatol Venereol; 1987; 114(1):25-37. PubMed ID: 3579130
    [No Abstract]   [Full Text] [Related]  

  • 27. Decline of anti-desmoglein 1 IgG ELISA scores by withdrawal of D-penicillamine in drug-induced pemphigus foliaceus.
    Nagao K; Tanikawa A; Yamamoto N; Amagai M
    Clin Exp Dermatol; 2005 Jan; 30(1):43-5. PubMed ID: 15663502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis.
    Shapiro M; Jimenez S; Werth VP
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):297-9. PubMed ID: 10642693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on immunofluorescent testing in bullous diseases and lupus erythematosus.
    Gately LE; Nesbitt LT
    Dermatol Clin; 1994 Jan; 12(1):133-42. PubMed ID: 8143377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing your diagnostic skills (#61). Case 2. Pemphigus vulgaris.
    Baughman R; Oxford GE; Painter R
    Todays FDA; 2002 May; 14(5):29, 31. PubMed ID: 12056213
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical and immunopathological heterogeneity of 22 cases of linear IgA bullous dermatosis.
    Sobjanek M; Sokolowska-Wojdylo M; Sztaba-Kania M; Barañska-Rybak W; Maciejewska A; Wlodarkiewicz A
    J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1131. PubMed ID: 18221336
    [No Abstract]   [Full Text] [Related]  

  • 32. Established methods in the investigation of bullous diseases.
    Mutasim DF; Pelc NJ; Supapannachart N
    Dermatol Clin; 1993 Jul; 11(3):399-418. PubMed ID: 8365028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpetiform pemphigus-like skin lesions induced by D-penicillamine.
    Morioka S; Ogawa H
    J Dermatol; 1980 Dec; 7(6):425-9. PubMed ID: 7026638
    [No Abstract]   [Full Text] [Related]  

  • 34. [Linear IgA dermatosis induced by penicillin G].
    Combemale P; Gavaud C; Cozzani E; Nicolas JF; Guennoc B; Dusseau JY
    Ann Dermatol Venereol; 1993; 120(11):847-8. PubMed ID: 8210142
    [No Abstract]   [Full Text] [Related]  

  • 35. Pemphigus in Mali: a study of 30 cases.
    Mahé A; Flageul B; Cissé I; Kéita S; Bobin P
    Br J Dermatol; 1996 Jan; 134(1):114-9. PubMed ID: 8745895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mixed immunoblistering disorder exhibiting features of bullous pemphigoid and pemphigus foliaceus associated with Spirulina algae intake.
    Kraigher O; Wohl Y; Gat A; Brenner S
    Int J Dermatol; 2008 Jan; 47(1):61-3. PubMed ID: 18173606
    [No Abstract]   [Full Text] [Related]  

  • 37. Penicillamine-induced type II bullous systemic lupus erythematosus.
    Condon C; Phelan M; Lyons JF
    Br J Dermatol; 1997 Mar; 136(3):474-5. PubMed ID: 9115947
    [No Abstract]   [Full Text] [Related]  

  • 38. Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels.
    Walsh SN; Kerchner K; Sangüeza OP
    Arch Dermatol; 2009 May; 145(5):603-4. PubMed ID: 19451516
    [No Abstract]   [Full Text] [Related]  

  • 39. Penicillamine-induced skin lesions.
    Sternlieb I; Fisher M; Scheinberg IH
    J Rheumatol Suppl; 1981; 7():149-54. PubMed ID: 6939877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug-induced pemphigus: clinical review and pathogenic mechanism].
    Civatte J
    Bull Acad Natl Med; 1986 Nov; 170(8):1057-63. PubMed ID: 3552140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.